Adhera Therapeutics Inc (ATRX)

[EOT]

Last 2 just left so with +400k I guess they would exercise their warrant options on the way out? See if a form4 hits. Need more updates…

[mrinvestor08]

No drugs left with Melior. Read recent 8k and let me know your thoughts.

[halbroke1]

ATRX $$$ IF THERE IS A BUYOUT/TAKEOVER OF THEIR MASSIVE WONDER DRUG, WE COULD SEE $10.00+ OR MORE HERE WITH THE CRAZY LOW SS, WHAT A HIDDEN GEM HERE !!!, SOMETHING HUGE COULD BE COOKING BEHIND THE SCENES...

[mrinvestor08]

9.1M shares now...hmmm

[EOT]

That’s why I say I’d rather a RM than anything.

[mrinvestor08]

If this is gonna become a RM play we might be sitting on a massive goldmine here...

And if the company coming in has revenue in the 100s of millions...oh boy

Next update should let us know what direction the company is going!

[EOT]

Adhera will still get royalties

[mrinvestor08]

Hmmm last min buy there. Let's see what next week brings!

[sc00pnDump]

I wonder on bdrx sub license from adhera.

[EOT]

Everyone gone, all doctors. Yet of all people this one stays with ceo lol
Geese I wonder why she stayed. To figure out the revenue…..LOL


Rhonda Stanley
Consultant
Ms. Stanley, CPA, is an accomplished financial professional with over a decade of financial leadership experience. She has broad finance and accounting experience including initial public offerings, mergers and acquisitions, reverse mergers, operations and management for life science and biotechnology companies. Ms. Stanley has served in a consulting role as the Senior Vice President of Finance & Accounting of Adhera Therapeutics since May 2019. Prior to that, she served as Chief Financial Officer of Asklepios Biopharmaceuticals, Inc. from May 2017 to 2018, as Chief Financial Officer of Bamboo Therapeutics Inc. (a privately held gene therapy company that was sold to Pfizer in 2016) from January 2016 to May 2017, as Vice President of Finance and Corporate Controller of Nephrogenix Inc. (NASDAQ: NRX) from 2014 to 2015, and as Corporate Controller and Chief Accounting Officer of Ocera Therapeutics Inc. from 2010 to 2014. Ms. Stanley earned an M.B.A. from Embry Riddle University, an Associate of Applied Science degree in Nursing from Sandhills Community College, and a B.S. in Accounting from Bradley University. Ms. Stanley, age 59, is a Certified Public Accountant who also served as a Captain in the U.S. Army Finance Corp.

[EOT]

That’s my point. it’s easy to remove, but they don’t. Maybe that’s Kucharchuk’s plan and finally pulled the trigger? This thing is debt free, cleaned up!

[mrinvestor08]

I've seen the shell stay on RM plays until it happens.

Is this a RM play who knows but IMO I think that is what is happening here...

Need another update to determine what is really going on here.

Nonetheless...I will now be adding tomorrow ;)

[EOT]

There’s zero reason for the shell to be there. I contacted otc and they said its up to the company to remove it, but they didn’t. And no websites.
What will they do next???….need a PR!

[mrinvestor08]

All different situations tbh...let's see what happens here within the next few weeks.

At this point we r guessing

[EOT]

Were they like this? This is the best I’ve seen!!!
Clean as a whistle!!!

[mrinvestor08]

I've been through a bunch...eng* and tcr*...anything possible let's see what this ceo is gonna do!

[mrinvestor08]

Unless they come out with some new business model launch bs...which I doubt will be better than being a pharma or rm play...let's see.

[EOT]

I REALLY like this idea better than them building up the company!!!! If a successful company making huge money took this over to go public, the stock would instantly realize the value of that company…. That would be amazing imo

Let’s see what happens next….

[EOT]

Well a QB is just one step from uplisting to Nasdaq. And they have already filed an S1. It’s a huge value right there. So any major company with great revenue wanting to go public this is a PREMIUM ticker!!!!!

[mrinvestor08]

Float 6.2m my guess is tightly held float is 3 m. Good luck

If there is a RM it depends what the company coming in is all about. That will dictate how high this can go.

[EOT]

We are not insiders so we don’t know anything until it happens. Lots of good guesses, but I’ve seen some reverse mergers with 100m os stocks and those were one day transformed. So this with 8m could be a major RM if that’s Their plan now???

No matter what happens. We don’t know the plan YET, but i really like the position of this stock!!! Imo it’s awesome!! And QB with no dilution.

[mrinvestor08]

Wondering if they still have that legacy asset and if they will develop that...seems like the melior ones were the best chances they had.

Looks like a RM in the making however as u can see from my posts i have been wrong many times...

Everything falling into place here!

[EOT]

“clean shell for a reverse merger wow just wow“

Wow is right.. I’ve never seen a better ticker for a RM….. what a beauty!!!

Tiny OS…..Clean clean clean!!!!!

[mrinvestor08]

Scoop 1 product gone in December from debt elimination deal...now last one gone too tied to melior...wondering if they still have this product mentioned on their otc profile?

In addition to advancing both drug candidates in Phase 2 clinical trials, the Company remains active in exploring other advanced drug development opportunities while maintaining its legacy assets, including CEQ508, an oral delivery of small interfering RNA (siRNA) against beta-catenin, to suppress polyps in the precancerous syndrome and orphan indication Familial Adenomatous Polyposis (FAP).

[sc00pnDump]

They want to do their own investigation drug testing , I think it said phase 2b on their own, further stating in the 8k

[mrinvestor08]

Debt gone...2 employees gone...last product agreement gone...clean shell for a reverse merger wow just wow

[mrinvestor08]

Pharma to reverse merger here...wow I'm so glad I loaded up from 0.01 to even 0.03. What a steal good luck guys and gals

[sc00pnDump]

Agreed, they stopped the agreement, yet you read further…. Merge is coming

Have a great day

[mrinvestor08]

Reverse merger incoming? Wow so now no more products....debt gone and money 640k in hand...

[sc00pnDump]

Nice news released now

[mrinvestor08]

Will add more by month end

[wedman]

Exactly

[EOT]

There are signs. Like the huge bids. Now they are moving up…… imo, big tell!!

Quiet until they’re not…..tic tok

[mrinvestor08]

Hopefully another 8k or news update soon....

[EOT]

Still 3 employees. Pretty sure they don’t need independent directors if they are going with a major partnership or some other deal?

Independent directors was dropped off otc.
Strange trading. Huge bids.

[mrinvestor08]

COMPANY OFFICERS & CONTACTS
Andrew Kucharchuk
CEO, COO
Rhonda Stanley
Consultant
BOARD OF DIRECTORS
Andrew Kucharchuk
Audit Committee Member
Charles L. Rice
Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member

[mrinvestor08]

Makes no sense to me to pay off all that debt then fire everybody and give up...something going on here.

[EOT]

The old ceo Andrew Kucharchuk is still there. He stepped down to let the new one do the great things he did. And will likely step back in??

Their Parkinson’s drug is their real baby so we shall see what comes next… the Andrew Kucharchuk ceo has the drug candidates connection with Melior Discovery family of companies.

[mrinvestor08]

This andrew guy has been there for a few years...wonder what next steps are here. Very very quiet hmmm

[mrinvestor08]

2 leaving the same day? Seems like they didnt leave on their own...why would they after closing a deal like this.

Also, I find it interesting that in 2022 the other dude had a disagreement with comp...got re hired...and this time around no disagreement with the company noted...

And not a peep regarding the deal too...we had to look through bdrx filings for that.

[EOT]

He seems like more of a facilitator to align big pharma deals than anything else. That’s his experience anyway….


“and have been instrumental in establishing more than 40 collaborations and co-operative agreements with major pharmaceutical and biotech companies, “


“I have over 30 years’ experience in the multinational pharmaceutical and biotechnology industries spanning senior roles in Research and Development, Marketing, Sales and Strategic Planning, including managerial positions with Sanofi-Aventis, GlaxoSmithKline, DuPont-Merck Pharmaceuticals, Gemini Genomics Inc. and Locus Pharmaceuticals Inc. Key positions held include: Head of Marketing and Sales, Vice President, Marketing and Business Development, and Chief Business Officer. I was also previously CEO of Nuevolution A/S based in Copenhagen, Denmark (acquired by Amgen) and CEO of Marillion Pharmaceuticals Inc. Presently I serve as Executive Chairman of Eppin Pharma Inc and CEO of Aestas Pharma Inc, both emerging biopharmaceutical companies. I have also raised over $50MM from venture capital firms to fund biotechnology enterprises, and have been instrumental in establishing more than 40 collaborations and co-operative agreements with major pharmaceutical and biotech companies, including licensing, co-marketing and acquisition transactions valued in excess of $600MM. Other career highlights include the successful launches of "blockbuster" drugs, including Imitrex®, Celexa®, Prinivil®/Zestril®, Sinemet CR® and Viazem®/Tiazac®, and the successful $100 MM IPO of Gemini Genomics Inc. and it's subsequent $220MM sale to Sequenom Inc.“

[mrinvestor08]

Why leave after paying off all that debt? Odd how they both left on Jan 12...

[EOT]

Maybe the ceo arranged something with another company he’s already in?

Because of their Parkinson’s drug, I find it very intriguing ….. let’s see what comes next?

[mrinvestor08]

Ceo and board member resigned

[EOT]

“So far the real deal for an OTC Ceo. eliminating 8 million of debt is unheard of“

Interesting…. He took over as ceo just recently, got the deal to eliminate all atrx debt then resigned. Wow. Something is cooking here…..

I like the sound of a big pharma partnership or buyout with their Parkinson’s drug….

[EOT]

“eliminating 8 million of debt is unheard of”

Yes this was a big deal they haven’t spoken of YET..

“Hopefully I found the one here”

Like most…Time will tell, but looks good to me imo.

[mrinvestor08]

So far the real deal for an OTC Ceo...eliminating 8 million of debt is unheard of...Hopefully I found the one here ;)

[EOT]

This guy has made many big pharma $bil’s.
Now he has his own baby…..ATRX.
I posted his plans before so let’s see what he does with his own stock…



Zahed Subhan
Chairman, CEO

CAREER HIGHLIGHTS

“I have over 30 years’ experience in the multinational pharmaceutical and biotechnology industries spanning senior roles in Research and Development, Marketing, Sales and Strategic Planning, including managerial positions with Sanofi-Aventis, GlaxoSmithKline, DuPont-Merck Pharmaceuticals, Gemini Genomics Inc. and Locus Pharmaceuticals Inc. Key positions held include: Head of Marketing and Sales, Vice President, Marketing and Business Development, and Chief Business Officer. I was also previously CEO of Nuevolution A/S based in Copenhagen, Denmark (acquired by Amgen) and CEO of Marillion Pharmaceuticals Inc. Presently I serve as Executive Chairman of Eppin Pharma Inc and CEO of Aestas Pharma Inc, both emerging biopharmaceutical companies. I have also raised over $50MM from venture capital firms to fund biotechnology enterprises, and have been instrumental in establishing more than 40 collaborations and co-operative agreements with major pharmaceutical and biotech companies, including licensing, co-marketing and acquisition transactions valued in excess of $600MM. Other career highlights include the successful launches of "blockbuster" drugs, including Imitrex®, Celexa®, Prinivil®/Zestril®, Sinemet CR® and Viazem®/Tiazac®, and the successful $100 MM IPO of Gemini Genomics Inc. and it's subsequent $220MM sale to Sequenom Inc.“

[EOT]

MAJOR developments have already happened! How are they going to move forward with their Parkinson’s drug++??
So they have to make an announcement soon….

[mrinvestor08]

Don't be scared to drop some news atrx management team!